@article{a51d0a150ab040118f4e2cb15ae35029,
title = "Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers",
abstract = "Molecular imaging has proven to be a powerful tool for investigation of parkinsonian disorders. One current challenge is to identify biomarkers of early changes that may predict the clinical trajectory of parkinsonian disorders. Exciting new tracer developments hold the potential for in vivo markers of underlying pathology. Herein, we provide an overview of molecular imaging advances and how these approaches help us to understand PD and atypical parkinsonisms.",
keywords = "FDG, PET, Parkinson's disease, acetylcholine, amyloid, atypical parkinsonism, dopamine, serotonin, tau",
author = "{on behalf of IPMDS-Neuroimaging Study Group} and Strafella, {Antonio P.} and Bohnen, {Nicolaas I.} and Perlmutter, {Joel S.} and David Eidelberg and Nicola Pavese and {Van Eimeren}, Thilo and Paola Piccini and Marios Politis and Stephane Thobois and Roberto Ceravolo and Makoto Higuchi and Valtteri Kaasinen and Mario Masellis and Peralta, {M. Cecilia} and Ignacio Obeso and Pineda-Pardo, {Jose {\'A}ngel} and Roberto Cilia and Benedicte Ballanger and Martin Niethammer and Stoessl, {Jon A.}",
note = "Publisher Copyright: {\textcopyright} 2016 International Parkinson and Movement Disorder Society",
year = "2017",
month = feb,
day = "1",
doi = "10.1002/mds.26907",
language = "English",
volume = "32",
pages = "181--192",
journal = "Movement Disorders",
issn = "0885-3185",
number = "2",
}